These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 10596957)

  • 1. Does the uncertainty of commonly performed glucose measurements allow identification of individuals at high risk for diabetes?
    Kallner A; Waldenström J
    Clin Chem Lab Med; 1999 Sep; 37(9):907-12. PubMed ID: 10596957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cut-off points of fasting fingertip capillary blood glucose for detecting both undiagnosed diabetes and pre-diabetes].
    Zhang YL; Guo SQ; Ma WB; Wang J; Bai GQ; Yang Q; Ti SF; Ma R; Wei RP; Liu WX; Li Z; Yang L; Liu DW; Li ZH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2010 Oct; 31(10):1174-8. PubMed ID: 21162825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fasting, non-fasting glucose and HDL dysfunction in risk of pre-diabetes, diabetes, and coronary disease in non-diabetic adults.
    Onat A; Can G; Çiçek G; Ayhan E; Doğan Y; Kaya H
    Acta Diabetol; 2013 Aug; 50(4):519-28. PubMed ID: 21769500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fasting cut-offs in determining the prevalence of diabetes and intermediate glucose abnormality in a non-obese population.
    Sayeed MA; Mahtab H; Khanam PA; Keramat Ali SM; Chowdhury RI; Vaaler S; Hussain A; Azad Khan AK
    Bangladesh Med Res Counc Bull; 2004 Dec; 30(3):105-14. PubMed ID: 16240981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Borderline type, impaired glucose tolerance (IGT), and impaired fasting glucose (IFG): their concepts, classification and significance].
    Kuzuya T
    Nihon Rinsho; 2005 Feb; 63 Suppl 2():15-20. PubMed ID: 15779339
    [No Abstract]   [Full Text] [Related]  

  • 6. Features of isolated post-challenge hyperglycaemia in Jamaican adults.
    Boyne MS; Sargeant LA; Bennett FI; Cooper RS; Wilks RJ; Forrester TE
    West Indian Med J; 2004 Jan; 53(1):7-11. PubMed ID: 15114886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of the WHO 1985 criteria and the proposed new diagnostic criteria on the prevalence of diabetes in an elderly population.
    Hiltunen LA; Keinänen-Kiukaanniemi SM
    Scand J Public Health; 2000 Dec; 28(4):266-9. PubMed ID: 11228113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of impaired fasting glucose on the incidence and prognosis of atherosclerosis in various vascular regions].
    Espinola-Klein C; Rupprecht HJ; Blankenberg S; Bickel C; Fossmeyer U; Kopp H; Victor A; Peetz D; Lackner K
    Z Kardiol; 2004; 93 Suppl 4():IV48-55. PubMed ID: 15085366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to minimize missing those subjects with high 2HR plasma glucose but 'normal' fasting plasma glucose levels?
    Ko GT; Cockram CS; Chan JC
    J Med; 2001; 32(1-2):53-65. PubMed ID: 11321888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting and post-glucose load--reference limits for peripheral venous plasma glucose concentration in pregnant women.
    Jørgensen LG; Schytte T; Brandslund I; Stahl M; Petersen PH; Andersen B
    Clin Chem Lab Med; 2003 Feb; 41(2):187-99. PubMed ID: 12667006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Burden and Disease and Mortality Risk Associated with Impaired Fasting Glucose in Elderly Adults.
    Samaras K; Crawford J; Lutgers HL; Campbell LV; Baune BT; Lux O; Brodaty H; Trollor JN; Sachdev P
    J Am Geriatr Soc; 2015 Jul; 63(7):1435-42. PubMed ID: 26147402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes screening after gestational diabetes mellitus: poor performance of fasting plasma glucose.
    Cypryk K; Czupryniak L; Wilczyński J; Lewiński A
    Acta Diabetol; 2004 Mar; 41(1):5-8. PubMed ID: 15057547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis.
    Mueller-Brandes C; Holl RW; Nastoll M; Ballmann M
    Eur Respir J; 2005 Apr; 25(4):715-7. PubMed ID: 15802348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe.
    Lancet; 1999 Aug; 354(9179):617-21. PubMed ID: 10466661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired fasting glucose (IFG) versus impaired glucose tolerance (IGT): the present scenario.
    Kundu AK
    J Assoc Physicians India; 2000 May; 48(5):551-2. PubMed ID: 11273166
    [No Abstract]   [Full Text] [Related]  

  • 16. An approach to establish the uncertainty budget of catalytic activity concentration measurements in a reference laboratory.
    Rami L; Canalias F
    Clin Chem Lab Med; 2015 Apr; 53(5):743-51. PubMed ID: 25283140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective Cardiovascular Münster.
    von Eckardstein A; Schulte H; Assmann G
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3101-8. PubMed ID: 10999793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice.
    Kim SH; Chunawala L; Linde R; Reaven GM
    J Am Coll Cardiol; 2006 Jul; 48(2):293-7. PubMed ID: 16843178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between bottom-up and top-down approaches in the estimation of measurement uncertainty.
    Lee JH; Choi JH; Youn JS; Cha YJ; Song W; Park AJ
    Clin Chem Lab Med; 2015 Jun; 53(7):1025-32. PubMed ID: 25539513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
    Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
    J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.